|
|
||||||||
Department of Molecular and Biomedical Science, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina
Correspondence and requests for reprints should be addressed to Kenneth B. Adler, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough Street at Wm. Moore Drive, Raleigh, NC 27606. E-mail: kenneth_adler{at}ncsu.edu
We have reported previously that MARCKS protein is a key regulatory molecule controlling mucin secretion by airway epithelial cells in vitro and in vivo, and presented evidence supporting a mechanism whereby MARCKS regulates secretion by translocating from plasma membrane to cytoplasm, where it binds to membranes of intracellular mucin granules (1, 2). The actual mechanism whereby MARCKS is targeted to and attaches onto membranes of mucin granules has not been elucidated. We hypothesized that two specific chaperone proteins, cysteine string protein (CSP) and heat shock protein 70 (Hsp/Hsc70), play important roles in this process, and do so by complexing with MARCKS on the mucin granule membrane. Both Hsp/Hsc70 and CSP were found to be present in normal human bronchial epithelial (NHBE) cells. CSP was localized to membranes of intracellular mucin granules, as determined by ultrastructural immunohistochemistry and Western blotting of isolated mucin granule membranes. Coimmunoprecipitation and Western blotting showed that CSP within these cells complexed with both MARCKS and Hsp/Hsc70. A peptide against the C-terminus of CSP added to NHBE cells attenuated mucin secretion in a concentration-dependent manner, whereas a control missense peptide had no effect. This C-terminal peptide also blocked binding of MARCKS to mucin granule membranes. Transfection of HBE1 cells, a virally transformed human airway epithelial cell line, with siRNA constructs against MARCKS, CSP, or Hsp70 attenuated mucin secretion, indicating that these proteins are involved in the process. The results suggest that CSP, and specifically its C-terminus, associates with membranes of mucin granules in airway secretory cells and, apparently in conjunction with Hsp/Hsc70, plays a role in MARCKS attachment to granule membranes during the secretory process.
FOOTNOTES
Supported by grant R37 HL36982 from the National Institutes of Health (K.B.A.).
Conflict of Interest Statement: J.P. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. S.F. does not have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. K.B.A. serves on the scientific advisory board of Sepracor, Inc., and received $5,000 for this service in 2005. He served as a consultant to Immunogen and received $1,500 in 2004. He received $68,000 in 20042005 as a research grant from AstraZeneca and approximately $40,000 in research grants from Sepracor since 2002. He holds 150,000 founders' shares of a start-up biotech company, BioMarck, and serves as a scientific consultant and member of the scientific advisory board without monetary compensation.
(Received in original form March 17, 2006; accepted in final form March 28, 2006)
REFERENCES
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |